PPIB and Candidiasis, Invasive: SCY-078 (formerly MK-3118, Fig. 1) is a derivative of enfumafungin and represents the first compound of the triterpene class of β-1,3-glucan synthesis inhibitors to reach clinical development for the treatment of invasive candidiasis.